For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, GoodRx Holdings Inc (NASDAQ: GDRX) closed at $8.80 down -0.56% from its previous closing price of $8.85. In other words, the price has decreased by -$0.56 from its previous closing price. On the day, 0.61 million shares were traded. GDRX stock price reached its highest trading level at $8.94 during the session, while it also had its lowest trading level at $8.65.
Ratios:
For a deeper understanding of GoodRx Holdings Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.19 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 22.42. For the most recent quarter (mrq), Quick Ratio is recorded 6.29 and its Current Ratio is at 6.29. In the meantime, Its Debt-to-Equity ratio is 1.13 whereas as Long-Term Debt/Eq ratio is at 1.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, RBC Capital Mkts on May 23, 2024, Upgraded its rating to Outperform and sets its target price to $10 from $8 previously.
On May 16, 2024, Raymond James Upgraded its rating to Outperform which previously was Mkt Perform but kept the price unchanged to $10.
KeyBanc Capital Markets Upgraded its Sector Weight to Overweight on April 10, 2024, while the target price for the stock was maintained at $9.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 30 ’23 when Wagner Scott bought 21,652 shares for $5.76 per share. The transaction valued at 124,806 led to the insider holds 182,900 shares of the business.
Wagner Scott bought 26,348 shares of GDRX for $155,482 on Nov 29 ’23. The insider now owns 161,248 shares after completing the transaction at $5.90 per share. On Nov 28 ’23, another insider, Wagner Scott, who serves as the insider of the company, bought 4,157 shares for $6.00 each. As a result, the insider paid 24,940 and bolstered with 134,900 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GDRX now has a Market Capitalization of 3302921728 and an Enterprise Value of 3478686976. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.32 while its Price-to-Book (P/B) ratio in mrq is 5.23. Its current Enterprise Value per Revenue stands at 4.552 whereas that against EBITDA is 45.136.
Stock Price History:
Over the past 52 weeks, GDRX has reached a high of $9.37, while it has fallen to a 52-week low of $4.14. The 50-Day Moving Average of the stock is 9.34%, while the 200-Day Moving Average is calculated to be 30.32%.
Shares Statistics:
For the past three months, GDRX has traded an average of 1.32M shares per day and 1070670 over the past ten days. A total of 92.36M shares are outstanding, with a floating share count of 77.28M. Insiders hold about 79.40% of the company’s shares, while institutions hold 14.87% stake in the company. Shares short for GDRX as of 1721001600 were 8351670 with a Short Ratio of 6.30, compared to 1718323200 on 8348353. Therefore, it implies a Short% of Shares Outstanding of 8351670 and a Short% of Float of 9.99.
Earnings Estimates
The current rating of GoodRx Holdings Inc (GDRX) is the result of assessments by 14.0 analysts actively engaged in evaluating its market dynamics.On average, analysts expect EPS of $0.09 for the current quarter, with a high estimate of $0.11 and a low estimate of $0.08, while EPS last year was $0.07. The consensus estimate for the next quarter is $0.09, with high estimates of $0.12 and low estimates of $0.08.
Analysts are recommending an EPS of between $0.44 and $0.32 for the fiscal current year, implying an average EPS of $0.36. EPS for the following year is $0.45, with 14.0 analysts recommending between $0.59 and $0.37.
Revenue Estimates
A total of 16 analysts believe the company’s revenue will be $200.49M this quarter.It ranges from a high estimate of $202.4M to a low estimate of $199.52M. As of the current estimate, GoodRx Holdings Inc’s year-ago sales were $189.68MFor the next quarter, 16 analysts are estimating revenue of $202.41M. There is a high estimate of $204.9M for the next quarter, whereas the lowest estimate is $200.43M.
A total of 18 analysts have provided revenue estimates for GDRX’s current fiscal year. The highest revenue estimate was $813.56M, while the lowest revenue estimate was $803.9M, resulting in an average revenue estimate of $806.49M. In the same quarter a year ago, actual revenue was $750.26MBased on 18 analysts’ estimates, the company’s revenue will be $885.4M in the next fiscal year. The high estimate is $920.44M and the low estimate is $846.24M.
